WHO ICTRP trial
A Study of Amivantamab and Lazertinib in Combination with Chemotherapy Compared…
CTRI/2022/01/039158 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2022/01/039158 |
|---|---|
| Public title | A Study of Amivantamab and Lazertinib in Combination with Chemotherapy Compared with Chemotherapy in Patients with Locally Advanced or Metastatic Non Small Cell Lung Cancer After Osimertinib Failure |
| Scientific title | A Phase 3 Open-Label Randomized Study of Amivantamab and Lazertinib in Combination with Platinum Based Chemotherapy Compared with Platinum Based Chemotherapy in Patients with EGFR Mutated Locally Advanced or Metastatic Non Small Cell Lung Cancer After Osimertinib Failure |
| Primary sponsor | Johnson and Johnson Private Limited |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | Argentina;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;Denmark;France;Germany;Hong Kong;India;Israel;Italy;Japan;Malaysia;Mexico;Netherlands;Poland;Portugal;Republic of Korea;Russian… |
| Conditions | Health Condition 1: C399- Malignant neoplasm of lower respiratory tract, part unspecified |
| Interventions | Intervention1: Lazertinib: Participants will receive lazertinib tablets orally Intervention2: Amivantamab: Participants will receive amivantamab 1050mg intravenously for body weight less than 80kg and 1400 mg for body weight greater than or… |
| Registration date | May 1, 2022 |
| Target size | 500 |
| Secondary IDs | 61186372NSC3002 Amendment 1 dated 06 Aug 2021 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: